Solace Therapeutics
Prior to this, she served as Director of Marketing for Interlace Medical from March 2009 through January 2011. She continued on with Hologic post acquisition through October 2011 to help lead launch efforts of the MyoSure hysteroscopic fibroid removal franchise throughout Hologic’s sales organization both domestically and Internationally. Nicole has extensive experience within women’s health. She brings a successful track record for introducing new treatments and technologies within the medical device arena and has fostered numerous relationships within the industry and with key opinion leaders in Urology and Gynecology both domestically and internationally. She has held senior marketing roles with companies such as Candela Corporation, the Women’s Healthcare Division of Boston Scientific Corporation, Laboratory Corporation of America, Davol (a division of CR Bard), GE Medical, (formerly Datex-Ohmeda) and Bayer Diagnostics (formerly Ciba-Corning Diagnostics).
This person is not in any offices
Solace Therapeutics
Solace Therapeutics is an emerging medical device company focused on the development of non-surgical office-based treatments for common bladder disorders, such as stress urinary incontinence (SUI), Solace is dedicated to improving the patient’s quality of life by eliminating side effects typically associated with current drug and surgical therapies.